January 31, 2019 |
13:05 PM PST
INVESTOR RATING
Download the REPCD Research Report
STOCK BACKGROUND
Biotricity is a modern medical technology company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity’s R&D continues to focus on the preventative healthcare market, with a vision of putting health management into the hands of the individual. The company aims to support the self-management of critical and chronic conditions with the use of innovative solutions to ease the growing burden on the healthcare system.
RECENT MEMBER ARTICLES ON BTCY – Biotricity
Report: How the Internet of Medical Things (IoMT) is Transforming Medtech
A recent Deloitte report outlines how the Internet of Medical Things (IoMT) is transforming medtech and health care with one small cap stock being a good example of company cashing in on the space.
Internet of Medical Things (IoMT): Revolutionizing the Home Healthcare Industry
According to a recent report from Frost & Sullivan, the Internet of Medical Things (IoMT) is helping to drive the home healthcare industry into new innovations that are clustered around wearables and eSkin devices – the type of devices that small cap Biotricity Inc (OTCQB: BTCY) is developing.
Biotricity Reports 150% Device Sales Increase
Small cap Internet of Medical Things (IoMT) company Biotricity Inc (OTCQB: BTCY) has just released operational updates for fiscal Q2 2018 – including a 150% increase in total device sales and a 75% increase in new customers from Q1.
Enhancing the Value of Medical Wearables
Consumer wearables like Fitbit and the Apple Watch along with deep data and artificial intelligence (AI) all bode well for medical wearables like Biotricity Inc’s Bioflux and Biopatch.
Biotricity Expands Research Into Fetal and Maternal Applications
Small cap Internet of Medical Things (IoMT) company Biotricity, Inc (OTCBB: BTCY) is expanding heart rate variability (HRV) research to cover both fetal and maternal HRV as current maternal monitoring solutions do not offer an application that combines accuracy with comfort and the highest standards of non-invasive patient safety.
SIMILAR ARTICLES
January 31, 2019 |
12:50 PM PST
January 31, 2019 |
12:41 PM PST